'Direct medical costs' presentation slideshows

VAP: A Preventable Disease

VAP: A Preventable Disease. Ruben D Restrepo MD RRT FAARC Professor of Respiratory Care The University of Texas Health Science Center at San Antonio. Disclosure: Ruben D. Restrepo, MD, RRT, FAARC. Teleflex Medical Speaker Member, Medical Advisory Board Oridion Capnography (Covidien)

1.03k views • 81 slides

Beyond ROI: Making the Business Case for Worksite Health Promotion

Beyond ROI: Making the Business Case for Worksite Health Promotion. George J. Pfeiffer President The WorkCare Group, Inc. P.O. Box 2053 Charlottesville, VA 22902 (434) 977-7525 georgeworkcare@ earthlink.net IAWHP Executive Summit, April 7, 2010. Critters. What Are We Going to Cover?.

684 views • 68 slides

The Cost-Effectiveness of Interventions in Health and Medicine

The Cost-Effectiveness of Interventions in Health and Medicine. William H. Herman, M.D., M.P.H. University of Michigan. Rationale for conducting cost-effectiveness analyses How is cost-effectiveness assessed? What is the cost-effectiveness of diabetes prevention?.

595 views • 59 slides

FQHC Cost Reporting

FQHC Cost Reporting. CEO and CFO working together June 22, 2012. Who do we have in the room?. CFOs and Accountants CEOs, COOs , and non-accountant types. Non-accountants. Gap is a store, not generally accepted accounting principles ( GAAP ).

569 views • 40 slides

Principles of Pharmacoeconomics

Principles of Pharmacoeconomics. Kem P. Krueger, Pharm.D., Ph.D. Kimberly Braxton Lloyd, Pharm.D. Auburn University School of Pharmacy. Cost Determination. Lecture 2. Objectives. Compare and contrast direct, indirect, and intangible costs

2.51k views • 36 slides

Cost Effectiveness of CT Screening in the National Lung Screening Trial

Cost Effectiveness of CT Screening in the National Lung Screening Trial. William C. Black, M.D. Dartmouth-Hitchcock Medical Center NLST CEA Writing Team. Writing Team. Methods Base case results Subset & sensitivity analyses Limitations. Outline. Comparison: LDCT, CXR, No Screen

477 views • 27 slides

Costing out interventions in D & I Research

Costing out interventions in D & I Research. Tzeyu Michaud, PhD Department of Health Promotion, UNMC tzeyu.michaud@unmc.edu. Overview. Role of costs in dissemination & implementation research Principle of costing Cost data collection guide Example/ template.

312 views • 22 slides

How Oregon State Agencies and Universities Walk the Talk October 10, 2011 OPHA Annual Conference

204 views • 20 slides

Cost-Effectiveness of Screening in the National Lung Screening Trial

Cost-Effectiveness of Screening in the National Lung Screening Trial. William C. Black, MD Dartmouth-Hitchcock Medical Center. Working Group. NLST CEA. Comparison: LDCT vs CXR vs None Effectiveness: LYs and QALYs Costs: $ US (reference 2009) Perspective: Societal

384 views • 17 slides

The Burden of Obesity in North Carolina

The Burden of Obesity in North Carolina. Obesity Costs. U.S. Costs. The direct medical costs of obesity in the U.S. have been estimated to be greater than $92 billion a year.

203 views • 13 slides

Purpose

90 views • 1 slides